RMD - UBS likes Lilly in premarket analyst action January, 23 2019 08:47 AM ResMed Inc. Alnylam Pharmaceuticals (NASDAQ:ALNY) initiated with Neutral rating at UBS. More news on: Alnylam Pharmaceuticals, Inc., Atara Biotherapeutics, Elanco, Healthcare stocks news, Stocks on the move, , Read more ...